Evidence map›Paper›PMID 25303853›Full record

ArticleJournal of inherited metabolic disease2015

High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders.

Sebastian Franik, Hidde H Huidekoper, Gepke Visser, Maaike de Vries, Lonneke de Boer, Marion Hermans-Peters, Richard Rodenburg, Chris Verhaak, Arine M Vlieger, Jan A M Smeitink and 2 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of inherited metabolic disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Sebastian FranikNijmegen Centre for Mitochondrial Disorders (NCMD) at the Amalia Children's Hospital, Radboudumc, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Hidde H Huidekoper
Gepke Visser
Maaike de Vries
Lonneke de Boer
Marion Hermans-Peters
Richard Rodenburg
Chris Verhaak
Arine M Vlieger
Jan A M Smeitink
Mirian C H Janssen
Saskia B Wortmann
Radboud University Medical Center · NLAmalia Kinderziekenhuis · NLRadboud University Nijmegen · NLAcademic Medical Center · NLSt. Antonius Ziekenhuis · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite major advances in understanding the pathophysiology of mitochondrial diseases, clinical management of these conditions remains largely supportive, and no effective treatment is available. We therefore assumed that the burden of disease combined with the lack of adequate treatment leaves open a big market for complementary and alternative medicine use. The objective of this study was to evaluate the use and perceived effectiveness of complementary and alternative medicine in children and adults with genetically proven mitochondrial disease. The reported use was surprisingly high, with 88% of children and 91% of adults having used some kind of complementary and alternative medicine in the last 2 years. Also, the mean cost of these treatments was impressive, being <euro>489/year for children and <euro>359/year for adult patients. Over-the-counter remedies (e.g., food supplements, homeopathy) and self-help techniques (e.g., Reiki, yoga) were the most frequently used complementary and alternative therapies in our cohort: 54% of children and 60% of adults reported the various complementary and alternative medicine therapies to be effective. Given the fact that currently no effective treatment exists, further research toward the different therapies is needed, as our study clearly demonstrates that such therapies are highly sought after by affected patients.

Indexed as

AdolescentAdultAgedChildChild, PreschoolComplementary TherapiesFemaleHumansMaleMiddle AgedMitochondrial DiseasesNonprescription DrugsPerceptionSurveys and QuestionnairesTreatment OutcomeYoung AdultNonprescription Drugs

Identifiers

PMID25303853
OpenAlexW1986921019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.